Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 15, 2026 07:00 ET | Source: Loblaw Companies Limited - Joe Fresh

Rethink s’associe à Joe Fresh(MC) et à la Fondation Pharmaprix pour la santé des femmes(MC)

TORONTO, 15 oct. 2026 (GLOBE NEWSWIRE) -- Rethink Breast Cancer, l’organisme de bienfaisance qui repense l’avenir des jeunes femmes touchées par le cancer du sein, est fier de s’associer à...
October 15, 2026 07:00 ET | Source: Adlai Nortye Group Ltd.

Adlai Nortye Enters into Clinical Collaboration with Lilly and Merck KGaA, Darmstadt, Germany to Evaluate Combination of AN4035 and Cetuximab

AN4035, a first-in-class investigational pan-RAS(ON) inhibitor-based ADC, will be evaluated as monotherapy and in combination with cetuximab in the ongoing global Phase I trial Cetuximab will be...
October 15, 2026 07:00 ET | Source: Tilray Brands, Inc.

SweetWater Brewing Gives Fans the Chance to Win Tickets to Their Dream Show at AEG Venues Across Georgia

ATLANTA, Oct. 15, 2026 (GLOBE NEWSWIRE) -- SweetWater Brewing, the iconic Atlanta-born craft brewery and a craft brand by Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), is turning up the volume...
October 15, 2026 07:00 ET | Source: Seres Therapeutics, Inc.

Seres Therapeutics to Present Preclinical Data for SER-428, an Investigational Live Biotherapeutic Designed to Reduce Risk of Bloodstream Infections in Critically Ill Patients, at IDWeek 2026

Novel oral liquid formulation of SER-428 is designed for patients who cannot take oral capsules, including critically ill patients receiving nutrition via feeding tube SER-428 significantly reduced...
October 15, 2026 07:00 ET | Source: Copper Road Resources Inc.

Copper Road Signs Exploration Agreement with the Matachewan First Nation on the Ben Nevis Volcanic Complex Project

Copper Road Resources Inc. (TSXV: CRD) has signed a milestone Exploration Agreement with Matachewan First Nation, a member of the Wabun Tribal Council.
October 15, 2026 07:00 ET | Source: Aquestive Therapeutics, Inc.

Aquestive Therapeutics Announces FDA Acceptance of Anaphylm™ NDA Resubmission and PDUFA Goal Date of March 16, 2027

FDA accepted the resubmission as complete and classified it as a Class 2 responsePrescription Drug User Fee Act (PDUFA) goal action date set for March 16, 2027Ex-U.S. strategy remains on track with...
October 15, 2026 07:00 ET | Source: Cronos Group Inc.

Cronos Completes Acquisition of CanAdelaar, Europe’s Largest Adult-Use Cannabis Company

Cronos acquires CanAdelaar for a base purchase price of €57.5 million plus cash earnout of 0.5x Normalized EBITDA1 in 2026 and 2027 Establishes Cronos’ European platform with #1 market share2 in the...
October 15, 2026 07:00 ET | Source: ADMA Biologics, Inc.

ADMA Biologics Announces Peer-Reviewed Publication Highlighting New Data From Its Optimized, Proprietary IVIG Manufacturing Process

Optimized Process Demonstrated Effective Removal of Procoagulant Impurities While Maintaining Immunoglobulin Quality and Increasing IgG Yield No Thromboembolic Events Were Reported for ADMA IVIG...
October 15, 2026 07:00 ET | Source: Xali Gold Corp.

Xali Gold Appoints Susan Mitchell as Senior Financial Advisor

VANCOUVER, British Columbia, Oct. 15, 2026 (GLOBE NEWSWIRE) -- Xali Gold Corp. (TSXV:XGC) (“Xali Gold” or the “Company”) is pleased to announce the appointment of Susan J. Mitchell as Senior...
October 15, 2026 07:00 ET | Source: Plug Power, Inc.

Plug Power Reports Continued Business Progress, Sets Dates for Third Quarter 2026 Earnings Call and Global Plug Symposium

Plug Power reports continued progress, record low $28M net cash usage, and announces Q3 earnings call Nov. 9 and global Plug Symposium Nov. 19.